C12N 2750/14223
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2750/14223 (Virus like particles [vlp]) appears on 11 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 8
- Assignees
- 8
- Inventors
- 13
- Latest grant
- 13 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Immunogenic combination compositions and uses thereof13 Feb 2024US 11,896,636 B2Glaxosmithkline Biologicals SA
- Compositions and methods for treating, including preventing, parvovirus infections and related diseases18 May 2021US 11,008,367 B2University of Louisville Research Foundation, Inc.
- Compositions and methods for treating, including preventing, parvovirus infections and related diseases26 Feb 2019US 10,214,565 B2University of Louisville Research Foundation, Inc.
- Method for generating a parvovirus B19 virus-like particle29 Aug 2017US 9,744,228 B2Norvartis AG
- Parvovirus capsids6 May 2003US 6,558,676 B1The United States of America as represented by the Department of Health and Human Services
- Immunogenic combination compositions and uses thereof14 Mar 2024US 2024/0082329 A1Glaxosmithkline Biologicals SA
- Compositions and methods for treating, including preventing, parvovirus infections and related diseases23 Sep 2021US 2021/0292372 A1University of Louisville Research Foundation, Inc.
- Compositions and methods for treating, including preventing, parvovirus infections and related diseases4 Jul 2019US 2019/0202867 A1University of Louisville Research Foundation, Inc.
- Compositions and methods for treating, including preventing, parvovirus infections and related diseases19 Jan 2017US 2017/0015712 A1University of Louisville Research Foundation, Inc.
- Immunogenic combination compositions and uses thereof14 Aug 2014US 2014/0227346 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents
- B19 parvovirus capsids17US 5,508,186 AThe United States of America as represented by the Secretary of Health and Human Services · 1996
- Parvovirus capsids16US 6,132,732 AThe United States of America as represented by the Department of Health and Human Services · 2000
- Parvovirus capsids15US 6,001,371 AThe United States of America as represented by the Department of Health and Human Services · 1999
- Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines11US 6,287,815 B1Rijksuniversiteit te Leiden · 2001
- Parvovirus capsids6US 5,827,647 AThe United States of America as represented by the Department of Health and Human Services · 1998